Sign in
THAT Stock Price, Chart, Stats & News
Thalia Therapeutics Plc
Save
Thalia Therapeutics Plc (THAT) does not currently pay a dividend.
5.48M
Market cap
–
Current P/E
–
Forward P/E
THAT chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Thalia Therapeutics Plc, a specialized pharmaceutical company established in 1979 and headquartered in Chellaston, UK, focuses on developing advanced nanoparticle silica delivery systems. These innovative systems are designed to enhance the cellular uptake and effectiveness of various cancer treatments and vaccines. The company's product portfolio includes Nuvec, a unique silica nanoparticle delivery platform distinguished by its irregular surface structure that effectively encapsulates and safeguards genetic material such as siRNA, RNA, and DNA.
Similar securities
Based on sector and market capitalization
Report issue